MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions
View by Date

Thursday, June 8, 2017

1:15pm-2:45pm
How will new technology change deep brain stimulation programming?

G. Duffley, A. Schiewe, B. Lutz, J. Krüger, M. Okun (Salt Lake City, UT, USA)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Exhibit Hall C
1:15pm-2:45pm
Hypertension and Parkinson’s disease

B. Giordano, G. Pagano, J. Hood, N. Ferrara, M. Politis (London, United Kingdom)

Parkinson's Disease: Neuroimaging And Neurophysiology  ·  Exhibit Hall C
1:15pm-2:45pm
Hypometabolism in Orbitofrontal and Perirhinal Cortex is Associated with Impulse Control Disorder in Parkinson´s Disease

I. Navalpotro-Gomez, A. Botas-Peñín, F. Molinet-Dronda, C. Gasca-Salas, M. Carmona-Abellán, H. Jiménez-Urbieta, M. Delgado-Alvarado, A. Quiroga-Varela, B. Gago, M.C. Rodríguez-Oroz (San Sebastian, Spain)

Parkinson's Disease: Neuroimaging And Neurophysiology  ·  Exhibit Hall C
1:15pm-2:45pm
Hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC): a Mexican case report.

A. Kleinert-Altamirano, J. Patricio-Villagran, M. Fiesco-Roa, M. Gutierrez-Arriola (Tuxtla Gutierrez, Mexico)

Pediatric Movement Disorders  ·  Exhibit Hall C
1:15pm-2:45pm
Identification of the optimal carbidopa concentration in subcutaneously administered ND0612

L. Adar, T. Rachmilewitz Minei, S. Oren (Rehovot, Israel)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Exhibit Hall C
1:15pm-2:45pm
Immunomodulatory therapy in stiff-person syndrome (SPS): a controlled Rituximab-randomised study

M. Amarandei (Bucharest, Romania)

Other  ·  Exhibit Hall C
1:15pm-2:45pm
Impact of injection interval on patient satisfaction in the routine treatment of cervical dystonia with abobotulinumtoxinA

R. Trosch, V. Misra, P. Maisonobe, S. Om (Farmington Hills, MI, USA)

Dystonia  ·  Exhibit Hall C
1:15pm-2:45pm
Impacts of White Matter Hyperintensities on Limit of Stability in Drug-naïve, de novo Patients with Idiopathic Parkinson’s Disease

J.-H. Park, S.-K. Lee, T.-K. Lee (Bucheon-si, Republic of Korea)

Parkinson's Disease: Neuroimaging And Neurophysiology  ·  Exhibit Hall C
1:15pm-2:45pm
Impaired Pain Processing in Functional Dystonia

F. Morgante, A. Matinella, E. Andrenelli, C. Allegra, C. Terranova, P. Girlanda, M. Tinazzi (Messina, Italy)

Dystonia  ·  Exhibit Hall C
1:15pm-2:45pm
Impaired sensorimotor and visual networks in drug naive Parkinson’s disease based on graph theoretical analysis

H. Chen (Beijing, China)

Parkinson's Disease: Neuroimaging And Neurophysiology  ·  Exhibit Hall C
  • «Previous Page
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • 22
  • …
  • 41
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley